文献速递脑血管病认知障碍与痴呆

痴呆患者急性缺血性卒中溶栓治疗:瑞典注册研究

Thrombolysis in acute ischemic stroke in patients with dementia: A Swedish registry study.
PubMed 文献 · Neurology · 2017-10-06

本研究基于瑞典痴呆与卒中注册数据,比较合并痴呆的急性缺血性卒中患者(n=1356)与匹配的无痴呆患者(n=6755)接受静脉溶栓的机会及结局。结果显示痴呆患者接受溶栓的OR为0.68(95%CI 0.54-0.86),但仅在日常活动独立患者中差异不显著;溶栓后症状性颅内出血和3个月死亡无显著差异,但痴呆患者功能结局和居住状态更差。

要点

  • 痴呆患者接受静脉溶栓的机会显著低于无痴呆患者(OR 0.68)。
  • 在≤80岁患者中,痴呆与溶栓机会降低的关联持续存在(OR 0.58)。
  • 溶栓后痴呆患者症状性颅内出血和3个月死亡无显著增加,但功能结局更差。

核心结论

  • 年轻痴呆患者接受静脉溶栓的机会较低,但溶栓后症状性颅内出血和死亡无显著差异,功能结局更差。

研究设计与样本

  • 纵向队列研究,基于瑞典痴呆和卒中注册,纳入2010至2014年急性缺血性卒中患者,痴呆组1356例,匹配无痴呆组6755例。

主要发现

  • 痴呆组接受静脉溶栓94例(7.0%),无痴呆组639例(9.5%),痴呆组接受溶栓的OR为0.68(95%CI 0.54-0.86)。
  • 在日常活动独立患者中,痴呆状态与溶栓机会的关联不再显著(OR 0.79,95%CI 0.60-1.06)。
  • 在≤80岁患者中,痴呆组接受溶栓的OR为0.58(95%CI 0.36-0.94)。
  • 溶栓患者中,症状性颅内出血发生率痴呆组7.4% vs 无痴呆组7.3%,3个月死亡22.0% vs 18.8%,均无显著差异。
  • 调整分析显示,痴呆组3个月mRS评分和居住状态更差(均p < 0.001),mRS 5-6分比例痴呆组56.1% vs 无痴呆组28.1%。

临床怎么用

  • 对合并痴呆的急性缺血性卒中患者,尤其是年轻患者,应评估溶栓机会是否不足。
  • 溶栓决策时需综合考虑痴呆患者功能结局较差的风险,但症状性颅内出血和死亡风险未见显著增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare access to intravenous thrombolysis (IVT) for acute ischemic stroke (AIS) and its outcomes in patients with and without dementia. METHODS: This was a longitudinal cohort study of the Swedish dementia and stroke registries. Patients with preexisting dementia who had AIS from 2010 to 2014 (n = 1,356) were compared with matched patients without dementia (n = 6,755). We examined access to thrombolysis and its outcomes at 3 months (death, residency, and modified Rankin Scale [mRS] score). Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated with logistic and ordinal logistic regression. RESULTS: The median age at stroke onset was 83 years in both groups. IVT was administered to 94 (7.0%) patients with dementia and 639 (9.5%) patients without dementia. The OR of receiving IVT was 0.68 (95% CI 0.54-0.86) for patients with dementia. When the analysis was repeated exclusively among patients independent in everyday activities, dementia status was no longer significant (OR 0.79, 95% CI 0.60-1.06). However, differences persisted in patients ≤80 years of age (OR 0.58, 95% CI 0.36-0.94). In patients who received thrombolysis, the incidence of symptomatic intracerebral hemorrhage (sICH; 7.4% vs 7.3%) and death at 3 months (22.0% vs 18.8%) did not differ significantly between the 2 groups. However, mRS score and accommodation status were worse among patients with dementia after 3 months in adjusted analyses (both p < 0.001). Unfavorable outcomes with an mRS score of 5 to 6 were doubled in patients with dementia (56.1% vs 28.1%). CONCLUSIONS: Younger patients with dementia and AIS are less likely to receive IVT. Among patients receiving thrombolysis, there are no differences in sICH or death, although patients with dementia have worse accommodation and functional outcomes at 3 months.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Zupanic E, von Euler M, Kåreholt I, et al. Thrombolysis in acute ischemic stroke in patients with dementia: A Swedish registry study. Neurology. 2017. PMID: 28986410. doi:10.1212/WNL.0000000000004598

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。